Dwight Bonham

Dwight Bonham serves as a Contract Specialist within the Defense Health Agency (DHA), where he plays a critical role in executing mission-critical acquisitions that support the operational readiness of uniformed service members, retirees, and their families. He manages the full lifecycle of procurement actions for clinical, logistical, and technological services essential to DHA’s healthcare delivery network, including medical equipment, diagnostic technologies, pharmaceutical supply chain solutions, and health data infrastructure. His acquisitions are strategically aligned with DHA’s priorities in modernizing clinical workflows and ensuring secure, scalable health systems across global military medical installations. Bonham maintains consistent working relationships with a select group of established contractors, including Dependable On-Site Scan & Shred, Inc., Hanith Bioscience, LLC, Livion Technology, LLC, I-2-I Solutions, Inc., and Draeger Inc. These partnerships reflect a focus on specialized vendors providing secure document management, biotechnology solutions, medical device support, IT integration services, and critical care equipment. His contracting approach emphasizes performance-based outcomes, technical compliance, and long-term vendor reliability over transactional procurement. Notably, Bonham’s portfolio reflects a 100% preference for full and open competition, with no set-asides designated for 8(a), HUBZone, SDVOSB, or other socioeconomic programs. This pattern indicates a procurement strategy prioritizing technical capability, mission-critical performance, and supply chain resilience over socioeconomic targeting, consistent with DHA’s operational imperatives. His procurement focus centers on high-compliance domains including medical device servicing, pharmaceutical logistics, health information technology, and clinical support services. He routinely engages with vendors offering FDA-regulated equipment, secure data handling solutions, and precision diagnostic tools, demonstrating deep familiarity with federal acquisition regulations governing healthcare technology and biomedical procurement. His expertise ensures DHA’s medical infrastructure remains robust, interoperable, and ready for global deployment.